A Dose-Ranging, Phase II Study of the Efficacy and Safety of Alosetron in Men with Diarrhea-Predominant IBS

Lin Chang, Vanessa Z. Ameen, George E. Dukes, David McSorley, Eric G. Carter, Emeran A. Mayer

The American Journal of Gastroenterology · 2005 · 140 citations · 26 references

Abstract

Alosetron 1 mg twice daily provided adequate relief of IBS pain and discomfort, and improved stool consistency in men with diarrhea-predominant IBS.

References

26